Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2b Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis (CLN6 Batten Disease), Delivering the CLN6 Gene by Self-Complementary AAV9

NCT07582484 is registered in ClinicalTrials.gov with The Charlotte and Gwenyth Gray Foundation as lead sponsor.

NCT NCT07582484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2b Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis (CLN6 Batten Disease), Delivering the CLN6 Gene by Self-Complementary AAV9
Lead sponsor
The Charlotte and Gwenyth Gray Foundation
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

batten disease, batten's disease, cln6, neuronal ceroid lipofuscinosis, neuronal ceroid lipofuscinosis cln6